Impac Software and Amirsys(R) Announce Development of Integrated Solution for Anatomic Pathology

Thursday, September 25, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

SUNNYVALE, Calif., and SALT LAKE CITY, Sept. 25 ImpacSoftware, part of the Elekta Group and provider of information technologysolutions for anatomic pathology (AP) laboratories, and Amirsys, Inc., aleader in reference materials for radiology and pathology, today announced thedevelopment of an integration between PowerPath(R), Impac's AP laboratoryinformation system, and PathIQ(R), Amirsys' PathIQ ImmunoQuery immunostaindecision support system.

Important for hospitals, as well as independent labs, this integrationwill provide pathologists with immediate access to published referencematerials and antibody suggestions, resulting in more accurate, efficient andcomplete diagnoses for AP cases. It also will shorten the time it takes todetermine or verify accurate diagnoses -- providing the pathologist with anestimate of turnaround times if the test is performed in their laboratory orrequires a send out of slides.

"The integration of PathIQ ImmunoQuery with PowerPath helps hospitals orindependent labs promote cost-effective management of their internal antibodyand IHC resources," reports Elizabeth Hammond, M.D., FCAP, Executive Editorfor Pathology at Amirsys. "The integration of PowerPath and ImmunoQuery nowallow a lab to use the new PowerPath custom immunostain menu mapping featurebetween the lab's existing inventory and ImmunoQuery's extensive antibody menuand database. The system will then automatically compare the antibodies in thelab's own inventory to pathologist requested IHC panels and determine if therequested antibodies are 'available in-house,' 'available via send-out,' or'not typically supported.' The new integration can assist pathologists who usePowerPath to select first from in-house available immunostains whenevermedically appropriate, thereby promoting cost-effective management of IHCcosts. In addition, the integration helps streamline the pathologist'sworkflow by ensuring that the most effective immunostains possible areordered, thereby improving the quality of patient care. As an additionalbenefit, instead of separate logins for PowerPath and ImmunoQuery, the newintegration allows PowerPath users to simply access ImmunoQuery directly fromwithin PowerPath."

"Impac is excited to be working with Amirsys to provide access to thisservice directly from PowerPath," says George Rugg, Senior Vice President andGeneral Manager of Impac Software's LIS business unit. "Over the yearsthousands of pathologists from around the world have been using this valuabletool for training and as an aid in the diagnostic process. This partnershipreinforces Impac's commitment to integrate proven technologies."

PowerPath demonstrations will be available at the College of AmericanPathologists (CAP) Annual Meeting in San Diego, California, September 25-27.For additional information, visit Impac booth # 302, Amirsys at booth # 804,or visit and .

About Impac Software

Impac Software is part of the Elekta Group, a human care companypioneering significant innovations and clinical solutions for treating cancerand brain disorders. Impac's open integration to multiple healthcare data andimaging systems offers oncology-specific patient charting and practicemanagement, as well as best-of-breed systems for anatomic pathology, clinicallaboratory and cancer registry.

Today, Elekta solutions are used in over 5,000 hospitals globally, andevery day more than 100,000 patients receive diagnosis, treatment or follow-upwith the help of a solution from the Elekta Group. Elekta employs around 2,500employees globally. The corporate headquarter is located in Stockholm, Sweden,and the company is listed on the Nordic Exchange under the ticker EKTAb. Formore information about Elekta, please visit .

About Amirsys

Amirsys is a leading provider of imaging informatics and diagnosticrefe

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store